Eli Lilly
Eli Lilly and Company was formed in the United States in 1876. As of now, the corporation employs over 39 thousand people worldwide. The company specializes in global health initiatives, diabetes care, and a variety of other human health items. Eli Lilly presently sells its products in over 120 countries around the world. As of 2021, the firm ranked among the top pharmaceutical corporations in terms of both prescription revenue and R&D spending.
Eli Lilly and Company has a strong presence in biotechnology. They are well-known for creating novel therapies and treatments for various diseases and medical problems, including cancer, diabetes, and autoimmune disorders.
Eli Lilly and Company has a significant presence in the biotechnology business and invests extensively in R&D to enhance its biotech product range. They have several biotech medicines on the market and developing, such as monoclonal antibodies, gene therapies, and other novel treatments. Furthermore, the company works with other biotech and pharmaceutical firms to develop new medicines and technologies.
Trulicity was Eli Lilly's largest revenue generator in 2022, accounting for around 7.4 billion US dollars. Verzenio was the next most profitable medicine, garnering approximately 2.4 billion US dollars.
Eli Lilly is the maker of several of the world's most popular diabetic prescription medicines and therapies. In terms of revenue, Eli Lilly was the second-largest seller of anti-diabetic drugs in 2017. Trulicity, one of Eli Lilly's main medications used to treat type II diabetes, is expected to be the top anti-diabetic pharmaceutical by 2024.
Founded: 1876
Headquarters: Indianapolis, Indiana, U.S.
Website: https://www.lilly.com/
